GSK plc GSK reported fourth-quarter 2025 core earnings of 68 cents per American depositary share (ADS), which beat the Zacks Consensus Estimate of 64 cents. Core earnings increased 10% year over year ...
When you ask your mom from the back seat if we can get Sid Meier's Civilization, and she shoots you down by insisting, "We have Civilization at home," Millennia is the Civilization at home. That may ...
SUNRISE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The Trump ...
GSK plc announced that China’s National Medical Products Administration (NMPA) has approved a new indication for Trelegy Ellipta (fluticasone furoate/umeclidinium ...
Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, announces that its abbreviated new drug ...
Even as the Trump administration works to implement its most-favored-nation pricing system, the U.S. government continues to advance efforts to negotiate Medicare drug prices as enabled by the ...
The US federal government has named the next 15 medicines that will be subject to Medicare pricing negotiation and reductions due to come into effect at the start of 2028. The list has been announced ...
The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications Botox and ...
The Centers for Medicare and Medicaid Services (CMS) have announced the next 15 drugs whose prices will be negotiated as part of the third round of Medicare negotiations. This latest round of ...
Professors at Kyung Hee University connect artificial intelligence, communications and quantum science with clinical and industrial partners. In this Viewpoint, four professors discuss how uniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results